Revelation Partners, LLC is a private equity firm specializing in buyout, direct and fund of fund investments. It prefers to invest in late stage companies. The firm seeks to provide capital and liquidity to investors, companies, and funds. It also specializes in making secondary investments. The firm typically invests in healthcare sector with a focus on medical devices, biopharmaceuticals, healthcare information technology, and healthcare services. It typically invest between $5 million and $30 million with the ability to do larger deals in conjunction with the limited partners. The firm may also purchase the ownership of an existing investor who desires liquidity. It also provides follow on investments. The firm prefers to take majority stake in companies. Revelation Partners, LLC is based in San Francisco, California.

Revelation Partners

Managing Partner

Associate

Dren Bio raised $65000000 on 2022-06-14 in Series B

Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.

Dren Bio

SetPoint Medical raised $64000000 on 2021-01-27 in Venture Round

SetPoint Medical Corporation, a clinical-stage bioelectronic medicine company, develops implantable neuromodulation devices for treating patients with debilitating inflammatory diseases. SetPoint Medical Corporation was formerly known as Innovative Metabolics Inc. and changed its name to SetPoint Medical Corporation in July 2008. The company was incorporated in 2006 and is based in Valencia, California.

SetPoint Medical

Vertos Medical raised $28000000 on 2017-06-12 in Venture Round

Vertos Medical is a healthcare company that offers medical devices used in the treatment of common spinal diseases. The company commercializes the percutaneous treatment for lumbar spinal stenosis (LSS). It also offers minimally invasive lumbar decompression devices for the treatment of various forms of LSS. The company offers its devices in the United States. 

Vertos Medical, Inc. was founded by Dr. Dave Solsberg and Dr. Don Schomer in 2005 and is headquartered in Aliso Viejo, California, USA.

Vertos Medical

Gravie raised $89999976 on 2022-03-09 in Series E

Gravie is a health insurance marketplace designed to help consumers choose and buy insurance, pay for it, and manage all health care expenses in one place. Gravie specializes in the fields of health insurance, health care, and employer benefits.

It was founded in 2013 and headquartered in Minneapolis, Minnesota.

Gravie, Inc.

Providence Medical Technology raised $25000000 on 2018-09-20 in Venture Round

Providence Medical Technology is a privately-held medical device company focused on innovative solutions for cervical spinal conditions. The company has pioneered a proprietary approach to cervical fusion and has developed surgical instrumentation and implants that offer unique benefits to the $2 billion worldwide cervical spine market. The Providence family of products includes the DTRAX® Spinal Instrumentation System, CAVUX® intervertebral implants, and the ALLY® line of bone and facet screws. All products are shipped-sterile and single-use to maximize perioperative efficiency and ensure consistent quality and performance.

Providence Medical Technology

Endeavor BioMedicines raised $101000000 on 2022-02-07 in Series B

Endeavor BioMedicines is developing new treatments targeting the underlying causes of pulmonary fibrosis.

Endeavor BioMedicines

Genome Medical raised $14000000 on 2020-07-01 in Series B

Genome Medical, Inc. operates a platform that provides genetic consultation and medical consulting services to individuals. The company through its Genome Care Delivery technology platform provides genetic solutions in the areas of clinical care, such as cancer, cardio, proactive, reproductive, pediatric, and pharmacy. Genome Medical, Inc. was incorporated in 2016 and is based in South San Francisco, California.

Genome Medical

Aspen Neuroscience raised $147500000 on 2022-05-09 in Series B

Aspen Neuroscience, Inc. develops induced pluripotent stem cells to treat neurological conditions. Its products pipeline includes ANPD001, an autologous neuron replacement therapy in sporadic Parkinson disease; and ANPD002, a gene-edited autologous neuron replacement therapy for familial forms of Parkinson disease. The company was incorporated in 2018 and is based in San Diego, California.

Aspen Neuroscience

IntelyCare raised $115000000 on 2022-04-06 in Series C

IntelyCare offers a digital workforce augmentation platform that combines a gig-model application with advanced data science to optimize staff resources and close the widening gap between workforce supply and demand. IntelyCare is revolutionizing the antiquated healthcare staffing market, filling nursing shifts at three times the industry average and giving post-acute facilities the tools to predict and manage staffing needs. The company’s engaging mobile app empowers nursing professionals with access to flexible, on-demand work opportunities, reducing burnout and attrition while increasing productivity.

IntelyCare

SPR Therapeutics raised $37000000 on 2021-10-18 in Series D

SPRA Therapeutics is a medical device company that is commercializing pain treatments utilizing its proprietary peripheral nerve stimulation (PNS) products. They are developing a pipeline of neurostimulation pain therapies that will exploit the same physiologic mechanism of action, proprietary technology, and clinical approach. The first product to be commercialized is the SMARTPATCHâ„¢ PNS System, which is a short-term, minimally invasive system that is simple to deliver and can be used for up to 30 days to stimulate electrically a peripheral nerve to relieve pain.

SPR Therapeutics, LLC

HotSpot Therapeutics raised $100000000 on 2021-11-29 in Series C

HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment. The company's platform helps to identify hotspots and locate pathway treatments for cancer, metabolic and rare diseases, leverages a database of hotspot structures, harnessing the power of data science in its multidisciplinary approach to drug discovery enabling patients to get treatment against several diseases.

HotSpot Therapeutics

ClearCorrect raised an undisclosed amount on 2016-10-05 in Private Equity Round

ClearCorrect is the clear and simple choice. No wires. No brackets. Just clear, convenient comfort—every reason to smile. With ClearCorrect, your dentist or orthodontist can straighten your teeth using a series of clear, custom, removable aligners. Each aligner moves your teeth just a little bit at a time until you eventually get straight teeth.

ClearCorrect, LLC

Genome Medical raised $60000000 on 2021-08-30 in Series C

Click Therapeutics raised $52000000 on 2021-10-22 in Series B

Click Therapeutics, Inc. engineers, validates, develops, and commercializes digital therapeutics solutions to benefit people with unmet medical needs through cognitive and neurobehavioral modification. It develops and commercializes novel digital therapeutics for various indications, including smoking cessation, major depressive disorders, schizophrenia, insomnia, acute coronary syndrome, migraine, overactive bladder, chronic low back pain, and obesity. Click Therapeutics, Inc. was founded in 2012 and is based in New York, New York.

Click Therapeutics

Gravie raised $28000000 on 2021-03-18 in Series D

Nuvolo raised $31000000 on 2021-03-02 in Series C

Nuvolo Technologies Corporation provides a cloud-based enterprise asset management platform under the name ServiceNow. The company provides life-cycle management solutions for enterprise assets of clinics, laboratories, facilities, and manufacturers. Additionally, it offers implementation, support, tracking, reporting, and analytics solutions. The company has strategic partnerships with Atos, Fruition Partners, InSource, KPMG, and Unisys. Nuvolo Technologies Corporation was founded in 2013 and is based in Paramus, New Jersey with additional offices in London, United Kingdom; Sofia, Bulgaria; and Pune, India.

Nuvolo Technologies Corporation

Evidation Health raised $45000000 on 2020-07-01 in Series D

Evidation Health is a provider of a health data analytics platform designed to collect and analyze continuous behavior data and healthcare information so as to create better health outcomes. Its platform turns raw, high-frequency everyday behavior data from sensors, devices, speech, video, and other sources into new knowledge about health and disease, that enable individuals and innovative companies to understand and influence the everyday behaviors.

It was founded in 2012 and is headquartered in San Mateo, California.

Evidation Health

NeuroPace raised $33000000 on 2020-08-31 in Private Equity Round

NeuroPace, Inc. designs, develops, manufactures, and markets implantable devices for the treatment of neurological disorders with responsive stimulation. It offers RNS System, a medical device that monitors and responds to brain activity. The company’s RNS System consists of a small implantable neuro stimulator that is connected to leads that are placed in up to two seizure onset areas. NeuroPace, Inc. was founded in 1997 and is based in Mountain View, California.

NeuroPace

Arterys raised $28000000 on 2020-05-29 in Series C

Arterys is the market leader and the world's first internet platform for medical imaging. Its objective is to transform healthcare by transforming radiology. The Arterys platform is 100% web-based, AI-powered, and FDA-cleared, unlocking simple clinical solutions.

Arterys Inc.

SomaLogic raised $81000000 on 2020-12-23 in Series A

SomaLogic operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions. 

SomaLogic was founded in 1999 and is headquartered in Boulder, Colorado.

SomaLogic

Syapse raised $30000000 on 2020-05-28 in Series F

Syapse works with leading health systems, life sciences companies, and regulators to accelerate real-world evidence to improve the outcomes of cancer patients. By bringing these organizations together into the Syapse Learning Health Network, Syapse has built one of the world’s largest networks dedicated to improving outcomes in cancer care through improved precision medicine. Syapse and its partners are working towards a future in which all cancer patients have access to the quality of care they need.

The company was founded in 2008 and is headquartered in San Francisco, California.